3 min read
CareMetx: Jun 30, 2025 11:58:15 AM
For years, people living with metabolic dysfunction-associated steatohepatitis (MASH), formerly known as Non-Alcoholic Steatohepatitis (NASH) have...
1 min read
CareMetx: May 21, 2025 11:44:39 AM
At this year’s Asembia summit, CareMetx Chief Strategy Officer Greg Morris joined a live recording of the Syneos Health podcast Navigating Modern...
1 min read
CareMetx: May 1, 2025 10:15:38 AM
The Inflation Reduction Act (IRA) promised major wins for patients. In many ways, it’s delivering. But CareMetx's latest analysis reveals how those...
1 min read
CareMetx: Feb 4, 2025 2:17:41 PM
CareMetx recently surveyed over 100 industry leaders to better understand their challenges, goals, and the evolving patient services landscape. Scott...
3 min read
CareMetx: Jan 8, 2025 6:05:11 PM
For market access leaders, launching a new product can be a high stakes challenge. With nearly two-thirds of drug launches falling short of...
3 min read
CareMetx: Nov 15, 2024 12:26:13 PM
In the fast-paced world of specialty drug access, you need both people and technology to give patients the ideal level of support. Too often,...
1 min read
Timely access to therapy is crucial for improving health outcomes. However, most healthcare providers struggle with inefficient systems that...
3 min read
As someone who has spent my entire career advocating for patients, I’ve come to recognize the profound impact that hubs can have on the patient...
4 min read
CareMetx: Jul 25, 2024 9:23:14 AM
Industry leaders worldwide are harnessing the transformative power of artificial intelligence (AI) and machine learning (ML) to boost efficiency,...
2 min read
For patients requiring specialty medications, the care journey can be especially challenging. The more complicated the treatment administration plan,...
4 min read
CareMetx: Mar 3, 2022 3:55:21 PM
The past several years have been dramatic for the pharmaceutical industry as the number of specialty therapies on the market continue to rise- in...
2 min read
Job losses and resignations spurred by the pandemic- coupled with escalating drug costs- have made it increasingly difficult for some patients to...
